BackSkye Bioscience Overview

Skye Bioscience Long Term Debt

Track Skye Bioscience's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00
↓ 100.00% YoYΔ $-223.47M vs prior year quarter

Peer average

Loading

Skye Bioscience Long Term Debt History

Loading

Skye Bioscience vs. peers: Long Term Debt Comparison

Loading

Skye Bioscience Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Skye Bioscience (SKYE) FAQ

Skye Bioscience posts a long-term debt of $0 as of March 2026. That compares with $220M in the prior-year period — down 100.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Skye Bioscience's long-term debt was $220M. The latest reading is $0 — a 100.0% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of Skye Bioscience's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SKYE's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Skye Bioscience's other metric pages and overview cover the third.